Is Uzma Bhd on the SC Malaysia Shariah list?

Yes. Uzma Bhd (Bursa Malaysia Main Market, stock code 7250) is on the List of Shariah-Compliant Securities effective 29 May 2026. The list is reviewed twice a year, on the last Friday of May and November.

~ / markets / stocks / 7250

Is Uzma Bhd Shariah-compliant?

Q: Is Uzma Bhd Shariah-compliant?

According to Malaysia's regulator, yes: the Shariah Advisory Council of the Securities Commission Malaysia lists it as Shariah-compliant, effective 29 May 2026. Deengen does not issue fatwas; ask a qualified scholar for a ruling that applies to you.

Bursa Malaysia Main Market · stock code 7250

Yes, according to Malaysia's regulator: the Shariah Advisory Council of the Securities Commission Malaysia lists it as Shariah-compliant, effective 29 May 2026.

What official bodies say

Halal-leaningPublished decisions on record

Shariah Advisory Council, Securities Commission MalaysiaMalaysia · 29 May 2026
Permits
Classified as a Shariah-compliant security in the council's list effective 2026-05-29. The list is reviewed twice a year, on the last Friday of May and November.
SC Malaysia, List of Shariah-Compliant Securities

Get an email when a recognised body rules on Uzma Bhd

Only when a body publishes or changes a position. You confirm by email first and can stop in one click. A report of what was published, not a fatwa or advice.

The council screens each company's audited accounts: income from non-compliant activities must be under 5% of total income, and conventional cash and interest-bearing debt must each be under 33% of total assets. It also weighs public perception of the business. The next list is due on the last Friday of November.

All Bursa Shariah stocks886 securities on the SC list US stocksThe S&P 500, with ratios Zakat calculatorIncluding shares

Deengen does not issue fatwas or verdicts. Labels summarise decisions published by regulators, Shariah index boards and Shariah-supervised funds, dated and linked. Ratios are arithmetic from the company's own filings, shown next to published benchmarks, not a ruling. Nothing here is a recommendation to buy, sell or hold. Capital at risk. Ask a qualified scholar for a ruling that applies to you.